B-type natriuretic peptide-guided management and outcome in patients with obesity and dyspnea-Results from the BASEL study

American Heart Journal

Volumn 158, Issue 3, 2009, Pages 488-495

  Noveanu, Markus ^a   Breidthardt, Tobias ^a   Cayir, Sevgi ^a   Potocki, Mihael ^a   Laule, Kirsten ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DYSPNEA; FEMALE; HEALTH CARE COST; HEART FAILURE; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD;

EID: 68849117423     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.05.033     Document Type: Article

References (31)

1. Remme W.J., and Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
2. Savage D.D., et al. Considerations in the use of echocardiography in epidemiology. The Framingham Study. Hypertension 9 (1987) II40-II44
3. Bales, A.C., Sorrentino, M.J. Causes of congestive heart failure. Prompt diagnosis may affect prognosis. Postgrad Med, 1997;101(1):44-9, 54-6.
4. World Health Organisation. Obesity and overweight, Fact sheet N°311 (2006). http://www.who.int/mediacentre/factsheets/fs311/en/print.html Available at: http://www.who.int/mediacentre/factsheets/fs311/en/print.html. Accessed July 20, 2007
5. Hedley A.A., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-28450
6. Hubert H.B., et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983) 968-977
7. Kenchaiah S., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
8. Maisel A.S., et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41 (2003) 2010-2017
9. Wang T.J., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 109 (2004) 594-600
10. Daniels L.B., et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 151 (2006) 999-1005
11. Mueller C., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
12. Horwich T.B., et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 (2001) 789-795
13. Krauser D.G., et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149 (2005) 744-750
14. Licata G., et al. Salt-regulating hormones in young normotensive obese subjects. Effects of saline load. Hypertension 23 (1994) I20-I24
15. Messerli F.H., et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 66 (1982) 55-60
16. Sarzani R., et al. Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 19 (1996) 581-585
17. Morabito D., Vallotton M.B., and Lang U. Obesity is associated with impaired ventricular protein kinase C-MAP kinase signaling and altered ANP mRNA expression in the heart of adult Zucker rats. J Investig Med 49 (2001) 310-318
18. Sarzani R., et al. Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues. J Hypertens Suppl 11 (1993) S214-S215
19. Mehra M.R., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43 (2004) 1590-1595
20. Bayes-Genis A., et al. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med 167 (2007) 400-407
21. Das S.R., et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112 (2005) 2163-2168
22. Calle E.E., et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341 (1999) 1097-1105
23. Mehta L., et al. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol 99 (2007) 906-910
24. Uretsky S., et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 120 (2007) 863-870
25. Oreopoulos A., et al. Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obesity (Silver Spring) 16 (2008) 442-450
26. Horwich T.B., Hamilton M.A., and Fonarow G.C. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 47 (2006) 85-90
27. Levine B., et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
28. Anker S.D., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
29. Mohamed-Ali V., et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277 (1999) E971-E975
30. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316 (1987) 1429-1435
31. Ybarra J., Planas F., and Pou J.M. Aminoterminal pro-brain natriuretic peptide (NT-proBNP) and sleep-disordered breathing in morbidly obese females: a cross-sectional study. Diab Vasc Dis Res 5 (2008) 19-24